California State Teachers Retirement System An2 Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.78 - $21.53 $25,717 - $199,174	9,251 New	9,251 $30,000
Q1 2023 May 09, 2023	SELL	$7.94 - $15.6 $2,421 - $4,758	-305 Reduced 6.88%	4,131 $40,000
Q4 2022 Feb 14, 2023	BUY	$8.51 - $19.69 $21,623 - $50,032	2,541 Added 134.09%	4,436 $42,000
Q3 2022 Nov 18, 2022	SELL	$7.61 - $22.29 $669 - $1,961	-88 Reduced 4.44%	1,895 $33,000
Q2 2022 Aug 15, 2022	BUY	$7.7 - $18.82 $15,269 - $37,320	1,983 New	1,983 $15,000

Others Institutions Holding ANTX

# of Institutions

Shares Held

13.5M

Call Options Held

Put Options Held

Bml Capital Management, LLC Zionsville, IN

5.75M
Shares

$6.15 Million
3.62% of portfolio
Ra Capital Management, L.P. Boston, MA

2M
Shares

$2.14 Million
0.03% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

1.56M
Shares

$1.66 Million
0.22% of portfolio
Vanguard Group Inc Valley Forge, PA

1.04M
Shares

$1.11 Million
0.0% of portfolio
Acuitas Investments, LLC

446K
Shares

$476,987
0.23% of portfolio

View Full List

About AN2 Therapeutics, Inc.

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $20.8M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

More about ANTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account